Nectar Lifesciences shareholding pattern
NECLIFE
12.7
0.44 (-3.35%)Last updated on 20 Feb, 2026 | 15:29 IST
BUYSELL
Free Demat with Zero AMC*
Summary
For Year 2025-26, Nectar Lifesciences reports the following shareholding: Total Promoters at 44.91%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.52%, Domestic Institutional Investors at 5.84%, and Retail at 48.73%. This breakdown provides a quick snapshot of ownership distribution for Nectar Lifesciences in 2025-26.
Nectar Lifesciences FAQs
As of 02-2026, the promoter shareholding in Nectar Lifesciences stands at 44.91% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Nectar Lifesciences is 0.52% and 5.84% respectively.
The retail shareholding of the Nectar Lifesciences is 48.73%.
Changes in shareholding patterns of Nectar Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Nectar Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Nectar Lifesciences Associated Pages
